Swift sonic thrombolysisreduces risk of bleeding

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 4
Volume 31
Issue 4

A new endovascular sonic lysis system reduces the risk of hemorrhage by dissolving clots faster than conventional catheter thrombolysis or mechanically assisted thrombectomy devices.

A new endovascular sonic lysis system reduces the risk of hemorrhage by dissolving clots faster than conventional catheter thrombolysis or mechanically assisted thrombectomy devices.

Dr. Constantino Peña, an interventional radiologist at the Baptist Cardiac & Vascular Institute in Miami, showed how the procedure works during a live televised case demonstration at the 2009 International Symposium on Endovascular Therapy. A 74- year-old patient with a blocked leg artery underwent ultrasound-enhanced thrombolysis with a tenecteplase/heparin infusion.The procedure required only half the usual thrombolytic dose and ended with a dissolved clot 12 hours later. Other techniques need at least 24 hours to be effective, which heightens bleeding risks associated with thrombolytics. BCVI specialists have performed the procedure on more than 100 patients using this technique, Peña said.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.